Education
About Us
Working with TipRanks
Follow Us
Milestone Scientific (MLSS)
XASE:MLSS
MLSS Stock Chart & Stats
$0.29
$0.17(16.41%)
At close: 4:00 PM EST
$0.29
$0.17(16.41%)
Day’s Range― - ―
52-Week Range$0.22 - $1.35
Previous CloseN/A
Volume1.27M
Average Volume (3M)172.66K
Market Cap
$22.09M
Enterprise Value$21.80M
Total Cash (Recent Filing)$1.27M
Total Debt (Recent Filing)$1.09M
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Mar 27, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding78,628,914
10 Day Avg. Volume233,274
30 Day Avg. Volume172,658
Financial Highlights & Ratios
PEG Ratio0.43
Price to Book (P/B)13.13
Price to Sales (P/S)8.88
P/FCF Ratio-26.14
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue2.40
Enterprise Value/Gross Profit3.30
Enterprise Value/Ebitda-3.18
Forecast
1Y Price Target
$1.00Price Target Upside244.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Dental Revenue FoundationSteady growth in the Dental business provides a stable revenue base that can support investment and commercialization efforts for the CompuFlo System in the medical pain-management market.
Management LeadershipAppointment of a new CEO and a global head of sales and marketing has strengthened senior leadership, boosting brand visibility and improving capacity to engage recurring customers.
Medicare Reimbursement Enabling Targeted RolloutApproval by three Medicare Administrative Contractors enables focused marketing in approved regions, increasing the chance of deeper market penetration where reimbursement is established.
Bears Say
Execution Uncertainty For Expansion ProgramsAnnouncements of potential programs to expand the North American footprint lack detailed timelines and metrics, raising execution risk that could dampen investor confidence.
Market Access ConcentrationCommercial expansion relies heavily on a limited set of Medicare Administrative Contractor approvals, creating vulnerability if reimbursement uptake in those regions slows.
Medical Sales Traction RiskElusive sales traction in the Medical business has led analysts to lower revenue forecasts, signaling downside risk to near-term growth expectations.
Milestone Scientific News
MLSS FAQ
What was Milestone Scientific’s price range in the past 12 months?
Milestone Scientific lowest stock price was $0.22 and its highest was $1.35 in the past 12 months.
What is Milestone Scientific’s market cap?
Milestone Scientific’s market cap is $22.09M.
When is Milestone Scientific’s upcoming earnings report date?
Milestone Scientific’s upcoming earnings report date is Mar 27, 2026 which is in 54 days.
How were Milestone Scientific’s earnings last quarter?
Milestone Scientific released its earnings results on Nov 13, 2025. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.015 by $0.005.
Is Milestone Scientific overvalued?
According to Wall Street analysts Milestone Scientific’s price is currently Undervalued.
Does Milestone Scientific pay dividends?
Milestone Scientific does not currently pay dividends.
What is Milestone Scientific’s EPS estimate?
Milestone Scientific’s EPS estimate is -0.02.
How many shares outstanding does Milestone Scientific have?
Milestone Scientific has 78,628,914 shares outstanding.
What happened to Milestone Scientific’s price movement after its last earnings report?
Milestone Scientific reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.015. Following the earnings report the stock price went down -12.929%.
Which hedge fund is a major shareholder of Milestone Scientific?
Currently, no hedge funds are holding shares in MLSS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Milestone Scientific
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
MLSS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a positive sentiment due to successful cost management and strategic initiatives in the Dental segment, alongside progress in securing Medicare payment rates for CompuFlo. However, challenges remain in achieving domestic revenue growth and executing a broader commercial rollout of CompuFlo.View all MLSS earnings summariesMLSS Stock 12 Month Forecast
Average Price Target
$1.00
▲(244.83% Upside)
Technical Analysis
Retractable Technologies
―
Precision Optics Corporation
―
Nephros
―
Femasys
―
NexGel Inc
―
Ownership Overview
11.31% Insiders
3.31% Mutual Funds
0.12% Other Institutional Investors
82.74% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---